Ipsen SA annual operating expenses
2020
2021
2022
2023
2024
2025
Ipsen SA Operating Expenses Growth & History (IPN)
Ipsen SA's operating expenses was €2.23B for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.23B | −€225.9M | −9.19% |
| 2024 | 2024-12-31 | €2.46B | €539.9M | +28.13% |
| 2023 | 2023-12-31 | €1.92B | €20.4M | +1.07% |
| 2022 | 2022-12-31 | €1.90B | €163.0M | +9.39% |
| 2021 | 2021-12-31 | €1.74B | €65.0M | +3.89% |
| 2020 | 2020-12-31 | €1.67B | — | — |
Ipsen SA operating expenses trends
Over the last five fiscal years, Ipsen SA's operating expenses increased from €1.67B to €2.23B, a change of €562.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
reported and calculated operating expenses
TickerStat uses operating expenses reported in company official filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
